Age: 66.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Arthritis, Bursitis, SARS-CoV-2 test, Vaccination site discomfort, Vaccination site erythema
Clinical narrative: arthritis and bursitis flared extreme and expanded; arthritis and bursitis flared extreme and expanded; Injection site won''t heal.; red; tender; inflamed; itchy; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 66 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 04Oct2021 (Lot number: FC3184) at the age of 66 years as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "Osteoporosis" (unspecified if ongoing); "coccydynia" (unspecified if ongoing); "known allergies: Only environmental" (unspecified if ongoing); "known allergies: pet dander" (unspecified if ongoing); "arthritis and bursitis flared extreme and expanded" (ongoing); "arthritis and bursitis flared extreme and expanded" (ongoing). The patient took concomitant medications. Vaccination history included: Bnt162b2 (prev dose product: COVID 19 , prev dose brand: Pfizer, prev dose brand unknown: False, prev dose lot number: EL9269, prev dose lot unknown: False, prev dose administration date: 10Mar2021 prev dose dose number: 2), administration date: 10Mar2021, when the patient was 65 years old, for Covid-19 immunization; Bnt162b2 (prev dose product: COVID 19, prev dose brand: Pfizer, prev dose brand unknown: False, prev dose lot number: EL3247, prev dose lot unknown: False, prev dose administration date: 17Feb2021 prev dose dose number: 1), administration date: 17Feb2021, when the patient was 65 years old, for Covid-19 immunization. The following information was reported: BURSITIS (non-serious), ARTHRITIS (non-serious) all with onset 18Oct2021, outcome "not recovered" and all described as "arthritis and bursitis flared extreme and expanded"; VACCINATION SITE DISCOMFORT (non-serious) with onset 18Oct2021, outcome "not recovered", described as "Injection site won''t heal."; VACCINATION SITE ERYTHEMA (non-serious) with onset 18Oct2021, outcome "not recovered", described as "red"; VACCINATION SITE PAIN (non-serious) with onset 18Oct2021, outcome "not recovered", described as "tender"; VACCINATION SITE INFLAMMATION (non-serious) with onset 18Oct2021, outcome "not recovered", described as "inflamed"; VACCINATION SITE PRURITUS (non-serious) with onset 18Oct2021, outcome "not recovered", described as "itchy". The events "arthritis and bursitis flared extreme and expanded", "arthritis and bursitis flared extreme and expanded", "injection site won''t heal.", "red", "tender", "inflamed" and "itchy" were evaluated at the physician office visit. Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of bursitis, arthritis, vaccination site discomfort, vaccination site erythema, vaccination site pain, vaccination site inflammation, vaccination site pruritus.  Additional information: Treatment was received with steroid ointment for injection site; acetaminophen. No covid prior vaccination reported. Patient tested for covid post vaccination.  No follow-up attempts are possible. No further information is expected.